XML 17 R6.htm IDEA: XBRL DOCUMENT v3.21.1
Consolidated Statement of Stockholders' Equity Consolidated Statement of Stockholders' Equity - USD ($)
shares in Thousands
Total
Common Stock
Treasury Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (loss)
Retained Earnings
Shares, Issued, Beginning Balance at Dec. 28, 2019   53,696 15,530      
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance at Dec. 28, 2019 $ 1,167,874,000 $ 54,000 $ (526,580,000) $ 600,624,000 $ (6,718,000) $ 1,100,494,000
Stock options exercised, shares   384        
Stock options exercised, value 13,495,000 $ 0   13,495,000    
Restricted/Performance stock units vested   46        
Shares paid for tax withholding, shares   (8)        
Shares paid for tax withholding, value (1,424,000)     (1,424,000)    
Share-based Compensation Expense       11,272,000    
Share-based Compensation Expense $ 11,272,000          
Repurchases of common stock, shares (3) (3) (3)      
Repurchases of common stock, value $ (371,000)   $ (371,000)      
Income Tax Effects Allocated Directly to Equity, Cumulative Effect of Change in Accounting Principle 439,000          
Income Tax Effects Allocated Directly to Equity, Cumulative Effect of Change in Accounting Principle | Cumulative effect of adoption of ASU 2016-13           439,000
Net income 64,456,000         64,456,000
Unrealized losses from foreign currency translation adjustments (2,463,000)       (2,463,000)  
Shares, Issued, Ending Balance at Mar. 28, 2020   54,115 15,533      
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance at Mar. 28, 2020 1,253,278,000 $ 54,000 $ (526,951,000) 623,967,000 (9,181,000) 1,165,389,000
Shares, Issued, Beginning Balance at Jan. 02, 2021   55,251 15,993      
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance at Jan. 02, 2021 $ 1,407,640,000 $ 55,000 $ (638,736,000) 703,693,000 1,413,000 1,341,215,000
Stock options exercised, shares 61 61        
Stock options exercised, value $ 2,886,000 $ 0   2,886,000    
Restricted/Performance stock units vested   303        
Shares paid for tax withholding, shares   (68)        
Shares paid for tax withholding, value (16,691,000)     (16,691,000)    
Share-based Compensation Expense       12,708,000    
Share-based Compensation Expense $ 12,708,000          
Repurchases of common stock, shares (547) (547) (547)      
Repurchases of common stock, value $ (128,917,000)   $ (128,917,000)      
Net income 53,383,000         53,383,000
Unrealized losses from foreign currency translation adjustments (2,884,000)       (2,884,000)  
Shares, Issued, Ending Balance at Apr. 03, 2021   55,000 16,540      
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance at Apr. 03, 2021 $ 1,328,125,000 $ 55,000 $ (767,653,000) $ 702,596,000 $ (1,471,000) $ 1,394,598,000